Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE

(SHP)
 SummaryQuotesChartsNewsCalendarCompany 
Company
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on SHIRE
05/16TAKEDA PHARMACEUTICAL : Bracing for 383-B.-Yen Net Loss for FY 2019
AQ
05/14TAKEDA PHARMACEUTICAL : expects net loss in FY 2019 due to Shire buyout cost
AQ
04/26TAKEDA PHARMACEUTICAL : Revised Forecast of Consolidated Financials for FY2018
AQ
02/18TAKEDA PHARMACEUTICAL : Notice Regarding Issue of Hybrid Bonds to replace Senior..
AQ
02/15SHIRE : Annual results
CO
02/08Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Cli..
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/14TAKEDA PHARMACEUTICAL : Shire and SAIIDAC announce planned delisting of notes fr..
AQ
01/11SHIRE PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/11SHIRE : and SAIIDAC announce planned delisting of notes from the New York Stock ..
AQ
01/10TAKEDA PHARMACEUTICAL : Completes Acquisition of Shire, Becoming a Global, Value..
AQ
01/09TAKEDA PHARMACEUTICAL : completes acquisition of Shire
AQ
01/09SHIRE : De-listing and cancellation of trading of Shire Shares
AQ
01/09SHIRE : Takeda wraps up biggest Japanese deal in £46bn Shire pharma buyout
AQ
More news
News in other languages on SHIRE
01/08EN DIRECT DES MARCHES : Nissan, Dassault Aviation, STMicroelectronics, Sika, ..
01/07Les affaires reprennent dans la pharmacie
2018Le marché du M&A se prépare à une année 2019 moins faste
2018Les craintes sur les taux et le commerce font plier les actions en Europe
2018Point marchés-Les craintes sur les taux et le commerce font plier les actions..
More news
Analyst Recommendations on SHIRE
More recommendations
Sector news : Pharmaceuticals - NEC
03:17aGSK to sell two travel vaccines to Danish biotech firm
RE
03:06aASTRAZENECA : U.S. FDA approves AstraZeneca diabetes drug for treating heart fai..
RE
01:32aROCHE : Phase 3 Study of Tecentriq, Avastin Combination a Success
DJ
10/20SAFRAN : Star French banker Pigasse resigns from Lazard
RE
10/19JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 3rd Update
DJ
More sector news : Pharmaceuticals - NEC
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Howard Mayer Chief Medical Officer, Senior VP, Head-R&D
Amitabh Singh Director
Susan O'Reilly Secretary & Director
Anthony Denis Ahern Director
Nigel Coffey Director
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE0.00%0
JOHNSON & JOHNSON-1.05%337 021
ROCHE HOLDING AG18.49%250 869
MERCK AND COMPANY10.82%216 813
PFIZER-16.47%201 662
NOVARTIS15.95%198 751